Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 10,956 | 4,604 | 7,378 | 6,276 |
| Gross Profit | 10,956 | 4,604 | 7,378 | 6,276 |
| Operating Expenses | 46,762 | 30,699 | 21,118 | 18,902 |
| Operating Income | -35,806 | -26,095 | -13,740 | -12,626 |
| Interest Expense | 180 | 429 | 713 | 662 |
| Other Income | 1,851 | 607 | 360 | 420 |
| Pre-tax Income | -34,135 | -25,917 | -14,093 | -12,868 |
| Net Income Continuous | -34,135 | -25,917 | -14,093 | -12,868 |
| Net Income | $-34,135 | $-25,917 | $-14,093 | $-12,868 |
| EPS Basic Total Ops | -1.55 | -1.67 | -1.24 | -2.24 |
| EPS Basic Continuous Ops | -1.55 | -1.67 | -9.66 | -8.86 |
| EPS Diluted Total Ops | -1.55 | -1.67 | -1.24 | -2.24 |
| EPS Diluted Continuous Ops | -1.55 | -1.67 | -9.66 | -8.86 |
| EBITDA(a) | $-34,780 | $-24,789 | $-12,396 | $-11,223 |